Andrew Spaventa, the Chief Executive Officer of Singular Genomics Systems , Inc. (NASDAQ:OMIC), recently sold 800 shares of the company's common stock, totaling $15,912. The shares were sold at an ...

Singular Genomics Systems, Inc. (market cap: $50.32M), a company specializing in laboratory analytical instruments, has voluntarily amended its proxy statement following two lawsuits alleging ...

Researchers find a master epigenetic switch that activates silenced genes to compensate for their missing counterparts in a ...

Companies like Complete Genomics, Illumina, and Singular Genomics Systems lead the way in next-generation sequencing (NGS), while Eurofins Scientific and PCR Biosystems focus on diagnostics.

Companies like Complete Genomics, Illumina, and Singular Genomics Systems lead the way in next-generation sequencing (NGS), while Eurofins Scientific and PCR Biosystems focus on diagnostics. Cancer, ...

Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique (Transcriptomics ...

The investigation focuses on determining if the Singular Genomics board breached its fiduciary duties to shareholders. Singular Genomics announced on December 23, 2024, that it "has entered into a ...